Hengkang Medical Group Co.Ltd(002219)
Securities abbreviation: * ST Hengkang securities code: 002219 Announcement No.: 2022-015 Hengkang Medical Group Co.Ltd(002219) Manager
Announcement on the progress of reorganization
The manager of the company, the company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
Special tips:
1. Hengkang Medical Group Co.Ltd(002219) (hereinafter referred to as “company” or “Hengkang medical”) received the civil ruling, decision and notice served by Gansu Longnan intermediate people’s Court (hereinafter referred to as “Longnan intermediate people’s court”) on July 9, 2021. Longnan intermediate people’s court ruled to accept the reorganization application of the applicant Guangzhou Zhongtong Huida commercial factoring Co., Ltd. on July 8, 2021, and made the decision (2021) Gan 12 Po No. 1-1 on August 6, 2021, appointing Beijing JUNHE law firm and Gansu Jiezhou law firm as Hengkang Medical Group Co.Ltd(002219) managers, which were led by Lian Jing and Li Wenge of Gansu Jiezhou law firm served as the manager and principal.
2. The court has officially accepted the reorganization application of the company, and the company may be at risk of being ordered by the court to terminate the reorganization proceedings and declare bankruptcy due to the failure of reorganization. According to item (VI) of article 9.4.17 of the Listing Rules of Shenzhen Stock Exchange (revised in 2022) (hereinafter referred to as the “Listing Rules”), if the court decides that the company is bankrupt, the company’s shares will face the risk of delisting.
3. According to the relevant provisions of item (VII) of article 9.4.1 of the listing rules, the company’s shares will continue to be subject to the special treatment of superimposing “delisting risk warning”, the stock abbreviation will remain ” Hengkang Medical Group Co.Ltd(002219) “, and the stock code will remain unchanged.
See details disclosed by the company in China Securities News, Securities Daily, Shanghai Securities News, securities times and cninfo.com（ http://www.cn.info.com.cn. ）The announcement on the court ruling to accept the reorganization of the company (Announcement No.: 2021-066) and the announcement on changing the warning situation of the company’s stock trading risk (Announcement No.: 2021-067). The manager makes the following announcement on matters related to the progress of the company’s reorganization: I. progress of the reorganization
(I) confirmation and ruling of creditor’s rights and supplementary declaration
Longnan intermediate people’s court made civil ruling (2021) Gan 12 Po No. 1-2, which was verified according to the creditors’ meeting
Hengkang Medical Group Co.Ltd(002219)
The debtor and creditor have no objection to the creditor’s rights of 37 creditors such as Agricultural Bank Of China Limited(601288) Kangxian sub branch. According to paragraph 2 of Article 58 of the enterprise bankruptcy law of the people’s Republic of China, the debtor and creditor ruled to confirm the creditor’s rights of 37 creditors such as Agricultural Bank Of China Limited(601288) Kangxian sub branch.
At present, the manager accepts the supplementary claims declared by creditors according to law and continues to review the declared claims.
(II) selection of investors
The on-site evaluation meeting for the selection of Hengkang medical restructuring investors was held in Longnan intermediate people’s court. After the voting of the evaluation committee, Beijing new mileage Health Industry Group Co., Ltd. (hereinafter referred to as “new mileage”) won 7 votes and Zhongmin Medical Investment Co., Ltd. (hereinafter referred to as “Zhongmin medical”) won 6 votes. According to the evaluation rules, Xinli was selected as the reorganization investor of Hengkang medical, and Zhongmin medical was selected as the alternative reorganization investor.
Under the guidance and supervision of Longnan intermediate people’s court, the manager is negotiating and signing the reorganization investment agreement and other relevant documents with xinmileage. The manager will timely announce the progress of signing the agreement and continue to promote the work related to bankruptcy reorganization. (III) others
Hengkang medical received the attention letter on Hengkang Medical Group Co.Ltd(002219) from the company Department [2021] No. 483 from Shenzhen Stock Exchange on December 30, 2021. For details, please refer to the website of Shenzhen Stock Exchange（ http://reportdocs.static.szse.cn./UpFiles/fxklwxhj/LSD002219167044.pdfrandom=0.9516583808857977 ）。
The company and the manager apply to Shenzhen stock exchange for an extension to complete the reply and disclosure of the letter of concern. The company and the manager strive to complete the reply as soon as possible and fulfill the obligation of information disclosure in a timely manner as required. For details, please refer to the announcement on delaying the reply to the letter of concern (Announcement No.: 2022-007) on January 15, 2022.
2、 On the postponement of the submission of the draft reorganization plan, the postponement of the creditors’ meeting and the cancellation of the investors’ group meeting
In accordance with paragraph 2 of Article 79 of the enterprise bankruptcy law of the people’s Republic of China, Longnan intermediate people’s court ruled that the deadline for submitting the draft reorganization plan should be extended to April 7, 2022.
According to the application of the manager, Longnan intermediate people’s court agreed to postpone the convening of the second creditor’s meeting originally scheduled for January 18, 2022 and agreed to cancel the convening of the investor group meeting originally scheduled for January 18, 2022. The convening time of the second creditors’ meeting and the investor group meeting will be notified separately.
For details, please refer to securities times, Securities Daily, China Securities News, Shanghai Securities News and http://www.cn.info.com.cn published by the manager on January 15, 2022 On the decision of the court to postpone the submission of the draft reorganization plan and postpone the convening of the second creditors’ meeting and cancel the group meeting of investors
Hengkang Medical Group Co.Ltd(002219)
Announcement on the implementation of the proposal (Announcement No.: 2022-008).
3、 Risk warning
1. The court has accepted the application for company reorganization according to law. According to the relevant provisions of item (VII) of article 9.4.1 of the listing rules, the company’s shares will continue to be subject to the special treatment of “delisting risk warning”, the stock abbreviation will remain ” Hengkang Medical Group Co.Ltd(002219) “, and the stock code will remain unchanged. For details, please refer to http://www.cn.info.com.cn published on cninfo.com on July 12, 2021 Announcement on changing the warning situation of stock trading risk of the company.
2. After the company enters the reorganization procedure, according to the relevant provisions of the enterprise bankruptcy law of the people’s Republic of China, the company may be declared bankrupt due to the failure of reorganization. According to item (VI) of article 9.4.17 of the listing rules, if the court decides that the company is bankrupt, the company’s shares will face the risk of delisting. Please make careful decisions and pay attention to investment risks.
The manager will conscientiously perform the obligation of information disclosure in strict accordance with the listing rules and other relevant laws, regulations and rules, and timely disclose the progress of restructuring related matters. The information disclosure media designated by the company are securities times, Securities Daily, China Securities News, Shanghai Securities News and cninfo (www.cn. Info. Com. CN.), The information released by the manager shall be subject to the information disclosed in the above designated media. In view of the significant uncertainty of the company’s reorganization, please pay attention to the relevant announcements, make prudent decisions and pay attention to investment risks.
It is hereby announced.
Hengkang Medical Group Co.Ltd(002219) administrator
February 10, 2002
